Dr. Bhisham Chera, MD of the University of North Carolina Hospitals, Chapel Hill discusses the scientific rationale behind the attempt to de-intensify chemoradiotherapy for HPV-associated Carcinoma at ASTRO Head and Neck Conference.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content